Skip to main content

nl
fr
en
de

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Human medicines
Health Products
Medical devices and their accessories
Materiovigilance

Materiovigilance

What shall be notified?

Who should notify?

When must incidents be notified?

How should incidents be notified?

Last updated on 20/05/2009

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

23/01/2020

Survey on the use of benzodiazepines and related substances for sleep disorders in Belgium

23/01/2020

Clamoxyl I.V.-I.M. available again but discontinuation of its marketing is scheduled for the end of 2021

15/01/2020

Pilot project on simultaneous national scientific advice starts 1 February 2020

14/01/2020

www.notifieruneffetindesirable.be - www.eenbijwerkingmelden.be: more practical and user friendly online forms

All news

© 2016 - FAMHP

Site map
Disclaimer